Companies in Rehovot

Evogene is not a chemical producer and does not pretend to be. It is an Israeli computational chemistry company that uses AI and computational biology to discover new active ingredients — a discovery-and-development model rather than a bulk supply one. Listed on both NASDAQ and the Tel Aviv Stock Exchange (EVGN), it was founded in 2002 in Rehovot. What the company offers is access to platforms rather than products: ChemPass AI for generative small-molecule design, MicroBoost AI, agricultural biologicals through Lavie Bio, and crop protection molecules. Its operating divisions — Lavie Bio, AgPlenus, Canonic and Biomica — address different corners of the same problem, finding molecules that work before anyone has synthesized them at scale. The right buyer for this kind of company is not placing a purchase order. It is a business seeking new actives, improved formulations or co-development, and the engagement runs through R&D and licensing agreements instead. Evogene collaborates with major global chemical and pharmaceutical partners on exactly that basis. An initial conversation is most productive when it describes the target profile — the crop, the pest, the mechanism of action — and the stage the partner is at, since the terms differ substantially between early discovery and closer-to-market work.